ARKRAY USA Announces Expanded Indications for TechLITE Pen Needles
MINNEAPOLIS, October 1, 2020 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announces the Company’s TechLITE Pen Needles are now indicated for use with pen injector devices for the subcutaneous injection of drugs. Previously, TechLITE Pen Needles were intended for the use of insulin only.